WO2014151450A1 - Dispositif de distribution microfluidique - Google Patents

Dispositif de distribution microfluidique Download PDF

Info

Publication number
WO2014151450A1
WO2014151450A1 PCT/US2014/025753 US2014025753W WO2014151450A1 WO 2014151450 A1 WO2014151450 A1 WO 2014151450A1 US 2014025753 W US2014025753 W US 2014025753W WO 2014151450 A1 WO2014151450 A1 WO 2014151450A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
distributing device
microfiuidic
reagent
sample
Prior art date
Application number
PCT/US2014/025753
Other languages
English (en)
Inventor
David J. Ledden
Dafeng Chen
James E. Rasmussen
Original Assignee
Siemens Healthcare Diagnostics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc. filed Critical Siemens Healthcare Diagnostics Inc.
Priority to US14/776,172 priority Critical patent/US9416776B2/en
Priority to KR1020157029250A priority patent/KR101653701B1/ko
Priority to EP14769287.5A priority patent/EP2972331B1/fr
Priority to CN201480014839.9A priority patent/CN105026932B/zh
Publication of WO2014151450A1 publication Critical patent/WO2014151450A1/fr
Priority to US15/206,669 priority patent/US10105701B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002—Partitioning blood components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502738—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0605—Metering of fluids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14—Process control and prevention of errors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14—Process control and prevention of errors
    • B01L2200/142—Preventing evaporation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/16—Reagents, handling or storing thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0645—Electrodes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/087—Multiple sequential chambers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0887—Laminated structure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/16—Surface properties and coatings
    • B01L2300/161—Control and use of surface tension forces, e.g. hydrophobic, hydrophilic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/06—Valves, specific forms thereof
    • B01L2400/0688—Valves, specific forms thereof surface tension valves, capillary stop, capillary break
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/08—Regulating or influencing the flow resistance
    • B01L2400/084—Passive control of flow resistance

Definitions

  • inventive concepts disclosed and claimed herein generally relate to microfSuidic devices which have a plurality of channels for distributing portions of a fluid sample for analysis
  • Blood is a complex mixture of suspended cellular components (erythrocytes, leukocytes, and thrombocytes) and dissolved substances (e.g., electrolytes, proteins, lipids, carbohydrates, and amino acids).
  • erythrocytes, leukocytes, and thrombocytes e.g., erythrocytes, leukocytes, and thrombocytes
  • dissolved substances e.g., electrolytes, proteins, lipids, carbohydrates, and amino acids.
  • the anticoagulated whole blood specimen is allowed to stand for a sufficient length of time or the specimen is centrifuged, the ceils will sediment to the bottom of the test tube, leaving a supernatant fluid called blood plasma.
  • the principle difference between serum and plasma is that serum contains no fibrinogen.
  • the fibrinogen Is consumed in its conversion to an insoluble fibrin matrix which traps the ce!is and fonrss the clot.
  • Acid citrate dextrose (ACD) aiso chelates calcium. Citrate-stabilized blood results in better quality NA and DNA than other anticoagulants and yields more lymphocytes for culture. However, in liquid form, acid citrate dextrose dilutes plasma, and a dilution factor will have to be considered when calculating assay results, if variable volumes of blood are drawn from study participants, dilution can result in erroneous results if volumes are not carefully recorded.
  • the inventive concepts disclosed and claimed herein generally relate to using a microfiuidic distributing device containing one or more of microchannels, valves, mixing chambers, separation structures, and metering components for separaiing, distributing and treating, and then analyzing, fluid samples, particularly blood samples.
  • a microfiuidic device design may a!low for selective eapture of blood ceils and/or components, and/or piasma components, reaction of captured ce!!s and p!asma components, with detection reagents, and capture and/or isolation of blood cells and/or components, for example.
  • microfiuidic analysis devices and systems adapted to apportion, distribute, treat and optionally analyze small fluid samples of, for example, 0.1 to 20 pL, thereby making possible accurate and repeatable assays of th ana!ytes of interest in such samples
  • the microfiuidic device is designed for analysis of blood.
  • the devices have one or more microfiuidic analysis units each comprising a microchannel in fluid communication with an entry port which provides access for a small sample of fluid and for apportionment and distribution of the sample to a plurality of reagent mixing areas.
  • Each reagent mixing area has a microchannel leading to an outlet port which can be aligned to a test device for analyzing the treated sample.
  • the microfiuidic device of the presently claimed and disclosed inventive concepts may include one or more overflow chambers, reaction chambers, microconduits with capillary stops, and air vents.
  • the capillary stops when present, direct the fluid flo in a preferred direction.
  • the presently claimed and disclosed inventive concepts include a method of supplying a liquid sample to a microfiuidic analysis device in which liquid is introduced to a sample entry port, where from it flows through a microchannel by capillary forces or by other methods of passive or active propulsion info a reagent area (reaction chamber) where the liquid sampie is exposed to and mixed with a reagent.
  • the microchannels have capillary stops which comprise, for example, narrow passageways for directing flow of the fluid in the microchannel.
  • the presently claimed and disclosed inventive concepts include a kit for a sampie collection device comprising the microfiuidic distributing device and one or more test devices for analyzing the fluid sample treated in the microfiuidic distributing device.
  • the microchannels may be rendered selective as adhesion can be adjusted for a cell type or ceil components
  • the inventive concepts disclosed and claimed herein relate to using a microfiuidic distributing device to treat and analyze a single whole blood sample.
  • the blood sampie is supplied to an entry port of the microfiuidic distributing device.
  • the sample is routed (generally via active fluidics) to an area on the device to generate the appropriate sample types(s) for the assays requested.
  • the processed sampies then are routed to the desired test devices (e.g., test cartridges or test cards) for analysis and evaluation.
  • the invention in one embodiment, eliminates centrifugation of whole biood sample to generate plasma(s), whole blood, or hemoiyzed blood by using active fluidics, chemicals and membranes (or other cell separation technique).
  • a single whole blood sampie is placed on the microfiuidic distributing device that would, via vaives and microchannels, route the sample to form the appropriate sample types (processing) and to the test cartridge(s) for the assay(s) ordered.
  • the presently disclosed and claimed inventive concepts speed up sample processing and assay throughput.
  • the o icrofiuidic distributing device generally interfaces with several test devices (test cartridges, test cards, or test modules) or can be integrated into individual analyte specific test devices. Additional microfluidic distributing devices may be fluidly connected to one another i se uential processing,
  • inventive concepts disclosed and claimed herein also relate to uses of microfluidic distributing devices and one or more test devices in a kit or system for analyzing a treated portion of the fluid sample applied to th microfluidic distributing device.
  • Other objectives of the presently disclosed and claimed inventive concepts wiil become apparent upon a reading of the description supplied below.
  • FIG. 1 is a top plan view of an embodiment of a microfluidic distributing device constructed in accordance with the inventive concepts disclosed herein,
  • FIG. 2 is a sectional view taken along line 2-2 of FIG. 1
  • FIG. 3 is a schematic top plan view of a microfiuidic analysis system constructed in accordance with the presently disclosed and claimed inventive concepts whic empioys a microfiuidic distributing device as shown in FIG. 1.
  • FIG. 4 is a schematic top pla view of another embodiment of a microfiuidic analysis system constructed in accordance with the presently disclosed and daimed inventive concepts which empioys a microfiuidic distributing device as shown in FiG. 1.
  • FIG. 5 is a schematic top plan view of another embodiment of a microfiuidic analysis system constructed in accordance with the presently disclosed and claimed inventive concepts which empioys a microfiuidic distributing device as shown in FIG. 1 ,
  • FIG. 8 is a schematic side eievational view of another embodiment of a micfofluidic analysis system constructed in accordance with the presently disclosed and claimed inventive concepts which empioys a microfiuidic distributing device as shown in FIG. 1.
  • FIG. 7 is a schematic top plan view of another embodiment of a microfiuidic analysis system for use with an alternate microfiuidic distributing device and constructed in accordance with the presently disclosed and claimed inventive concepts.
  • inventive concepts are not limited in its application to the details of construction, experiments, exemplary data, and/or the arrangement of the components set forth in the following description, or illustrated in the drawings.
  • inventive concepts are capable of other embodiments or of being practiced or carried out in various ways.
  • phraseology and terminology employed herein is for purpose of description only and should not be regarded as limiting in any way unless specifically indicated as such.
  • reaction chamber refers to 1 or more, 2 or more, 3 or more, 4 or more or greater numbers of reaction chambers.
  • the term "reagent” refers to any element, compound, ion, or molecule wit which any portion of the fluid sample, or complex derived from the fluid sample, ma react, for example to form a detectable signal.
  • the reagents may be, but are not limited to, indicator dyes, metals, polymers, enzymes, proteins, peptides, nucleic acids, nucleotides, saccharides, lipids, antibodies, elecirochemically-reactive substances, chemicals, radioactive elements or compounds, labels, or other analytes known to persons having ordinary skill in the art.
  • the reagents may be placed on or incorporated into carriers (substrates) such as papers, membranes, polymers, or other carriers known in the art.
  • the reagents may be dry, or wet. More than one reagent may be placed on a carrier. Typical chemical reactions which involve the reagents include, but are not limited to, dye binding, enzymatic, immunologic, oxidation or reduction chemistries,
  • affinity reagent and any variations thereof, is intended to comprise reagents such as antibodies and oilier binding molecules, used to attract and retain specific ceil types.
  • affinity reagents are typically, but not necessarily, attached to a surface or may attract and retain one or more cells to a surface.
  • the term "detection reagent” and any variations thereof comprises one or more of a first molecule or cell (such as a peptide, an antibody, a nucleic acid, and combinations thereof, for example), which first molecule binds to a second target molecule or cell in order to identify or track such second target molecule or cell.
  • a detection agent is typica!iy, but not necessarily, unattached to a surface.
  • the same or similar molecules may function as a detection reagent when not attached to a surface, and as an affinity reagent when attached, deposited on, or otherwise connected with, a surface.
  • any reference to “one embodiment” or “an embodiment” means that a particular element, feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment.
  • the appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment,
  • the reagent used in the microflusdic distributing device is at least one Iyophiiized reagent.
  • the Iyophiiized reagent comprises, for example, at least one of a salt, a protein, and a catalyst.
  • the Iyophiiized reagent may be disposed in any form, such as but not limited to, a bead or a hemisphere.
  • the composition may be maintained in a substantially air tight environment until use thereof.
  • the iyophiiized reagent may include saSt(s), protein(s) and/or catalyst(s).
  • compositions that may be present in the iyophiiized reagent utilized in accordance wit the presently disclosed and claimed inventive concept(s) include, but are not limited to, sodium, potassium, calcium, and/or chlorine salts (such as but not limited to, calcium chloride, lithium chloride, sodium bicarbonate, sodium citrate, sodium sulfite, and/or sodium sulfate), glucose oxidase, glucose dehydrogenase, hexokinase, glucose dehydrogenase, hexokinase, lactate oxidase, hemoglobin, cobalt, and combinations thereof.
  • sodium, potassium, calcium, and/or chlorine salts such as but not limited to, calcium chloride, lithium chloride, sodium bicarbonate, sodium citrate, sodium sulfite, and/or sodium sulfate
  • glucose oxidase glucose dehydrogenase, hexokinase, glucose dehydrogenase, hexokinase,
  • the microfluidic distributing device may be equipped with a microprocessor chip and microcircuitry for controlling one or more aspects of operation of the device such as the opening and closing of valves and/or the active pumping of fluids.
  • the microprocessor may be programmed with a code which indentsfies one or more of the patient, the fluid sample, reagents in the device, or instructions for analysis of the fluid, for example.
  • the volume of the fluid sample which the microfluidic distributing device can receive can vary widely, for example between about 10 pL to about 1200 pL and is usually in a range from about 10 pL to about 40 L
  • the sample voiumes which the fluid sample is apportioned into can vary, but typically, such sampies have voiumes of about 1 ⁇ to 20 ⁇ per reagent, although they may range from 0.1 pL to 200 pL per reagent, for example, depending on the type of fluid sample and the number of portions into which the fluid sample is separated.
  • the microfiuidic distributing device in non-iimiting embodiments, may be made of plastics such as polycarbonate, polystyrene, poiyacrylaies, or polyurethane, alternatively or in addition to, they can be made from silicates, and/or glass.
  • th plastics preferably used may include, but are not limited to, ABS, acetals, acrylics, acrylonitriie, cellulose acetate, ethyl cellulose, aikyivinylaicohols, polyaryietherketones, poiyetheretherketones, po!yetherketones, melamine formaldehyde, phenolic formaldehyde, polyamides (e.g., nylon 6, nylo 8 ⁇ , nylon 12), polyamide-imide, poiydicycloperitadiene, polyether-imides, poiyethersulfones, poiyimides, poiy henyleneoxides, polyphthalamide, methylmethacryiate, polyurethanes, polysulfones, poiyethersulfones and vinyl formal.
  • ABS acetals
  • acrylics acrylonitriie
  • cellulose acetate ethyl cellulose
  • the plastics used to make the chi include, but are not limited to; polystyrene, polypropylene, polybuiadiene, poiybutylene, epoxies, TeflonTM, PET, PTFE and chloro-f!uoroethy!enes, polyvinylidene fluoride, PE-TFE, PE-CTFE, liquid crystal polymers, Mylar®, polyester, LDPE, HOPE, polymethyipentene, poly phenyls ne sulfide, polyolefins, PVC, and chlorinated PVC.
  • the various components of the presently disclosed and claimed invention can be provided as kits containing various combinations of th components described herein that can be assembled or used by the user and/or patient in the manners disclosed above.
  • the principle of operatio of the system of the presently claimed and disclosed inventive concepts is that the sample is provided to a reagent in a reagent area (reaction chamber) through the use of a unidirectional hydrophilic capillary flow principle where the sample flows from a sample entry port, through the reaction chamber, towards an exit port.
  • the microfiuidic distributing device may have a vent which is ope to air during flow of the fluid sample.
  • the microfiuidic distributing device may have active or passive valves for controlling flow, stopping, advancing, or inhibiting "backflow* of the subsampSes therein (as explained below for example).
  • microfiuidic distributing devices and sample analysis systems of the presently claimed and disclosed inventive concepts which may be used for analyzing a fluid sample according to the presently claimed and disclosed inventive concepts.
  • the fluid sample is generally from a biological source.
  • a "liquid” refers to any substance in a fluid state having no fixed shape but a substantially fixed volume,
  • microfiuidic distributing devices of the presently claimed and disclosed inventive concepts typically use smaller channels (referred to herein as microchanneis or microconduits) than have been used by previous workers in the field.
  • the microchanneis (microconduits) used in the presently claimed and disclosed inventive concept(s) typically have widths in the range of about 5 ⁇ - ⁇ to 1000 ⁇ , such as about 10 pm to 500 pm, whereas channels an order of magnitude larger have typically been used by others when capillary forces are used to move fluids.
  • Depths of the microchannels are typically in a range of 5 pm to 100 pm.
  • the minimum dimension for the microchannels is generally about 5 pm, unless it is desired to use smaller channels to filter out components in the sample being analyzed, it is aiso possible to control movement of the samples in the microchannels by treating the microchannels to become either hydrophi!ic or hydrophobic depending on whether fluid movement is desired or not.
  • the resistance to movement can b overcome by a pressure difference, for example, by applying pumping, vacuum, electroosmosis, heating, or additional capillary force. As a result, liquids can move from one region of the device to another as required for the analysis being carried out.
  • microfiuidic distributing devices of the presently ciaimed and disclosed Inventive concepts are generally small and flat, typically, but not limited to, about 0.5 to 2 square inches (12.5 to 50 mm 2 ⁇ or disks having, but not limited to, a radius of about 15 to 60 mm.
  • the volume of apportioned fluid sample introduced into a particular microfiuidic circuit will be small.
  • the sample typically will contain only about 0.1 to 10 pL for each assay, although the total volume of a specimen may range from 10 to 200 pL
  • the microfiuidic distributing device of the presently claimed and disclosed inventive concepts comprises a square or rectangular strip or card, or disk.
  • the microfiuidic distributing devices (chips) used in the presently claimed and disclosed inventive concepts generally are intended to be disposable after a single use. Generally, disposable chips will be made of inexpensive materials to the extent possible, while being compatible with the reagents and the samples which are to be analyzed.
  • microchannels of the microfluidic distributing devices described herein typically are hydrophilic, which in one embodiment is defined with respect to the contact angle formed at a soiid surface by a liquid sample or reagent. Typically, a surface is considered hydrophiiie if the contact angle is less than 90 s and hydrophobic if the contact angle is greater than 90". Plasma induced polymerization may be carried out at the surface of the passageways.
  • the microfluidic distributing devices of th presently claimed and disclosed inventive concepts may also be made with other methods used to control the surface energy of the capillary ⁇ microchannei ⁇ walls, such as coating with hydrophilic or hydrophobic materials, grafting, or corona treatments.
  • the surface energy of the capillary walls may be adjusted, i.e., the degree of hydrophi!icity or hydrophobicity, for use with the intended sample fluid, for example, to prevent deposits on the walls of a hydrophobic passageway or to assure that none of the liquid is left in a passageway.
  • the surface is generally hydrophilic since the liquid tends to wet the surface and the surface tension force causes the liquid to flow in the passageway.
  • the surface energy of capillary passageways can be adjusted by known methods so that the contact angle of water is between 10° to 60" when the passageway is to contact whole blood or a contact angle of 25° to 80° when the passageway is to contact urine.
  • Movement of liquids through the microchannels may be controlled or directed by capillary stops, which, as the name suggests, stop liquids from flowing through the capillary by a change in capillary forces.
  • capillary stops which, as the name suggests, stop liquids from flowing through the capillary by a change in capillary forces.
  • a more narrow capillary width can have a stronger stop strength than a less narrow capillary, thereby causing the fluid to move through the less narrow capillary in preference of movement through the more narrow capiilary.
  • Fluid flow in the devices of the presently ciaimed and disclosed inventive concepts may be initiated by capillary forces driven by atmospheric pressure although in some embodiments flow may be initiated or reinitiated by other external or active forces such as automatic pumps as discussed elsewhere herein.
  • the actual shape of the opening in the sample entry port may vary.
  • the shape of the opening is not considered to be critical to the performance, since severai shapes may be satisfactory.
  • it may be merely a circular opening into which the sample is placed.
  • the opening may be tapered to engage a corresponding shape in a pipette, capillary, or outlet which deposits the sample.
  • Suc ports may be sealed closed so that nothing can enter the microfluidic chip until the port is engaged by the device holding the sample fluid, such as a syringe or pipette.
  • the sample may be introduced fay a positive pressure, as when a plunger is used to force the sample into the entry port.
  • the sample may be merely placed at the opening of the entry port and capillary action used and atmospheric pressure to pull or push the sample into the microfluidic distributing device. Excess sample is preferably not to be left on a surface however, since cross-contamination may occur.
  • the sample may be placed at the opening of the entry port and a vacuum used to pull the sample into the microfluidic chip.
  • a vacuum used to pull the sample into the microfluidic chip.
  • biological samples contain water and the walls of the entry port and associated passageways will be hydropnilic so that the sample will be drawn into the mierofiuidic chip even in the absence of added pressure.
  • the mierofiuidic distributing device in certain embodiments contains mechanisms or means for separating cellular components from the plasma.
  • a separation area may contain membranes or giass fibers for separating red blood eel is from plasma so that they do not interfere with the analysis of plasma.
  • One or more blood anti-coagulants e.g., heparin, EDTA, oxalates, sodium citrate, acid citrate dextrose, and sodium fiuoride/potassium-oxalaie
  • hemolytic reagents may be Included to cause lysis of celis.
  • any one of the chambers or microchanneSs of the mierofiuidic distributing device may comprise microstructures known in the art which are used to assure uniform contact and mixing of the liquid sample with a reagent or other agent which has been disposed in the reagent area or in the microchannel.
  • the reagents are liquids which have been coated on a porous support and dried.
  • the microstructures may comprise an array of posts disposed in a reagent area so that the liquid sample must pass from the entry port in a non-linear, non- direct, direction. The liquid is constantly forced to change direction as it passes through the array of posts.
  • Each of the posts may contain one or more wedge- shaped cutouts which facilitate the movement of the liquid as discussed in U.S. Pat. No. 6,296,126, for example.
  • Other types of microstructures whic are usefu! are known to persons having ordinary skill in the art and include (but are not limited to) three dimensional post shapes with cross-sectional shapes that can be circles, stars, triangles, squares, pentagons, octagons, hexagons, heptagons, ellipses, aosses or rectangles or combinations thereof, ivlicrostructures with two-dimensional shapes such as a ramp leading up to reagents on plateaus may also be useful.
  • Microfluidic distributing devices of the presently claimed and disclosed inventive concepts have many applications. Analyses may be carried out on samples of many fluids of biological origin whic are fluids or have been fiuidized including, but not limited to, blood, piasma, serum, urine, bladder wash, saliva, sputum, spinal fluid, intestinal fluid, intraperitoneal fluid, food, cystic fluids, ascites, sweat, tears, feces, semen, nipple aspirates, and pus. As noted above, blood is of particular interest. Also included are processed biological fluids such as milk, juices, wines, beer, and liquors. Fluids of non-bio!ogicai origin or which may be contaminated, suc as water, are also included.
  • a sample of the fluid to be tested is deposited in the entry port of the microfluidic distributing device and subsequently apportioned into several subsampies which are distributed into a pluraiity of reaction chambers (reagent areas) to react with a reagent therein and to be analyzed after the reaction.
  • Biological samples analyzed herein may be obtained from any biological sample including humans or any other mammal, birds, fish, reptiles, amphibians, insects, crustaceans, marine animals, plants, fungi, and microorganisms. The reacted sample will be assayed for the substance, or ana!yte of interest.
  • the fluid sample may be assessed for contamination microoganisms such as E colt, Pseudomonas sp,, H, pylori, Streptococcus sp., Chlamydia and mononucleosis pathogens.
  • contamination microoganisms such as E colt, Pseudomonas sp,, H, pylori, Streptococcus sp., Chlamydia and mononucleosis pathogens.
  • Metals which may be detected include, but are not limited to, iron, manganese, sodium, potassium, lithium, calcium, and magnesium,
  • reagents may undergo changes whereby the intensity, nature, frequency, or type of the signal generated is proportional to the concentration of the ana!yte measured in the clinical specimen.
  • These reagents may contain indicator dyes, metals, enzymes, polymers, antibodies, electrochemically reactive ingredients and various other chemicals placed onto carriers (also referred to herein as reagent substrates).
  • Carriers often used are papers, membranes or polymers wit various sample uptake and transport properties.
  • Liquid reagents when used, are preferably isolated by barrier materials which prevent migration of water throughout the device, thus avoiding changes in the concentration through transpiration or evaporation and preventing moisture from reaching the dry reagents.
  • any method of detecting and measuring an analyte in a liquid sample ca be used in the microfiuidic devices of the presently claimed and disclosed inventive concepts.
  • assays for detecting ana!ytes are well known in the art and include, for example, enzyme inhibition assays, antibody stains, latex agglutination, and immunoassays, e.g., radioimmunoassay.
  • antibody herein is used in the broadest sense and refers to, for example, intact monoclonal antibodies, polyclonal antibodies, multispecific antibodies ⁇ e.g., bispecific antibodies), and to antibody fragments that exhibit the desired biological activity (e.g., antigen-binding).
  • the antibody can be of any type or class (e.g., IgG, IgE, Ig , fgD, and IgA) or subclass (e.g., !gG1 , lgG2, SgG3, SgG4, SgA1 and igA2).
  • Immunoassays as noted, including radioimmunoassay and enzyme-linked immunoassays, are useful i the methods of the presently claimed and disclosed inventive concepts.
  • a variety of immunoassa formats including, for example, competitive and non-competitive immunoassay formats, antigen capture assays and two-antibody sandwic assays can be used in the methods of the invention.
  • Enzyme-linked immunosorbent assays ELiSAs
  • an enzyme is typically conjugated to the second antibody, generally by means of glutaraldehyde or period ate.
  • glutaraldehyde or period ate As will be readily recognized, however, a wide variety of different conjugation techniques exist which are readily available to one skilled in the art.
  • the analytes are detected and measured using chemiluminescent detection.
  • chemiluminescent detection for example, in certain embodiments, ana!yte-specific antibodies are used to capture an analyte present in the biological sample and an antibody specific for the specific antibodies and labeled with an chemiluminescent label is used to detect the analyte present in the sample.
  • Any chemiluminescent label and detection system can be used in the present devices and methods.
  • Chemiluminescent secondary antibodies can be obtained commercially from various sources. Methods of detecting chemiiuminesceni secondary antibodies are known in the art and are not further discussed herein in detail,
  • Examples of assays that may be carried out during the use of the microfluidic distributing devices described herein include, but are not limited to, tests for blood gases, clotting factors, immunogens, bacteria, and proteins, in one embodiment the assays that may be detected with the test devic is a luminescent O2 channel assay 9 (LOCI®) which includes the use of for example, Sandwich Assays based on an ana!yte-specific antibody and a biotiny Sated antibody wherein specific wavelengths are generated by th fluid subsampie and detected by the test device.
  • LOCI® luminescent O2 channel assay 9
  • Reagent configurations for the assay method include for example Sandwich Formats based on an antigen or an antibody, a Competitive Format, or a Sandwich Format with Extended Linker and may be used in immunoassays, infectious disease testing, and DNA testing.
  • Specific biood chemicals which may be measured include, but are not limited to, TSH, free T4, free T3, Total PSA, free PSA, AFP, CEA, CA15.3, CA 19-9, CA 125, Cardiac Troponin-!, NT-pro BNP, myoglobin, mass CKMB ( B), BNP, Ferritin, Vitamin B 12: , Foiate, total B-HCG, FSH, LH, prolactin, estradiol, testosterone, progesterone, and digoxin.
  • Fluorescent detection also can be useful for detecting anaiytes in the presently claimed and disclosed inventive concepts.
  • Useful fluorochromes include, but are not limited to, DAPI, fluorescein, lanthanide metals, Hoechst 33258, R- phycocyanin, B-phycoerythrin, R-phycoerythrin, rhodamine, Texas red and lissamine. Fluorescent compounds, can be chemically coupled to antibodies without altering their binding capacity.
  • Radioimmunoassays can be useful i certain methods of the invention. Such assays are well known in the art. Radioimmunoassays can be performed, for example, with !abeled primary or secondary antibody.
  • Separation steps are possible in which an anaiyte is reacted with reagent in a first reaction chamber and then the reacted reagent or sample is directed to a second reaction chamber for further reaction, !n addition, a reagent can be re- suspended in a first reaction chamber and moved to a second reaction chamber for a reaction. An analyte or reagent can be trapped in a first or second chamber and a determination made of free versus bound reagent. The determination of a free versus bound reagent is particularly useful for multizone immunoassay and nucleic acid assays. There are various types of muifizon immunoassays that could be adapted to this device.
  • Immunoassays or DNA assay can be developed for detection of bacteria such as Gram negative species (e.g., £.
  • Immunoassays can be developed for complete panels of proteins and peptides such as albumin, hemoglobin, myoglobuiin, ct-1 -microglobulin, immunoglobulins, enzymes, glycoproteins, protease inhibitors, drugs and cytokines.
  • proteins and peptides such as albumin, hemoglobin, myoglobuiin, ct-1 -microglobulin, immunoglobulins, enzymes, glycoproteins, protease inhibitors, drugs and cytokines.
  • the device may be used in analysis of urine for one or more components therein or aspects thereof, such as, but not limited to, leukocytes, nitrites, urobilinogen, proteins, albumin, creatinine, uristatin, calcium oxalate, myoglobin, pH, blood, specific gravity, ketone, bilirubin and glucose.
  • leukocytes nitrites
  • urobilinogen proteins
  • albumin e.g., urobilinogen
  • albumin e.g., urobilinogen, proteins, albumin, creatinine, uristatin, calcium oxalate, myoglobin, pH, blood, specific gravity, ketone, bilirubin and glucose.
  • microfiuidic channel system 22 has a fluid sample entry port 24 in the base 12 for receiving a fluid sample from a fluid container (not shown) engaged with the microfiuidic distributing device 10,
  • the microfiuidic distributing device 10 may be referred to as a "chip,"
  • the microfiuidic distributing device 10 is generally small and fiat, having a shape and dimensions as discussed elsewher herein.
  • the microfiuidic distributing device 10 is shown as having a rectangular shape, however it will be understood that the shapes of the microfiuidic distributing devices of the presently claimed and disclosed inventive concepts, include but are not limited to, round, rectangular, trapezoidal, irregular, oval, star, or any other geometric shape which allows the microfiuidic passageways therein to function in accordance with the presently claimed and disclosed inventive concepts, it will be appreciated that there are several ways in which the various components of the microfiuidic channel system 22 can be formed In the base portion 12, such as, but not limited to, injection molding, laser ablation, diamond milling, embossing, and combinations thereof, for example.
  • the top cover 14 has an opening or area of weakness above the fluid sample entry port 24 in the base 12.
  • the top cover 14 may be transparent to allow for Imaging and observation of the fluid sample as it is passed through the microfiuidic channel system 22.
  • the top cover 14 may be secured ⁇ permanently or detaehably) to the base portion 12 in any suitable manner such as by molding, ultrasonic welding, radiofrequency welding, bonding, gluing, double-sided adhesive tapes, and combinations thereof, for example, provided that a substantially fSuid- im permeable connection is formed between the base portion 12 and the top cover 14 of the microfluidic distributing device 10.
  • the microfluidic distributing device 10 may be reusable o disposable depending on the intended use. In one embodiment, the microfluidic distributing device 10 may be disposed of after a single use.
  • the microfluidic distributing device 10 is generally made of inexpensiv materials to the extent possible, while being compatible with the reagents and the samples which are to be analyzed.
  • the microfluidic distributing device 10 may be made of plastics, such as polycarbonate, polystyrene, po!yacryiates, or poiyurethene, or other materials, such as silicates, silicone, ceramics, glass, wax, resins, metals, and combinations thereof but is not limited to such materials. Other materials which may be used are described elsewhere herein.
  • the microfluidic channel system 22 comprises a plurality of microchannel s into which fluid samples are introduced and analyzed.
  • the microfluidic channel system 22 of FIG. 1A and 1 B includes a microchannel 26, a second microchanne! 28, a third microchanne! 30, and a fourth microchannel 32,
  • the first microchanne! 26 is intended, for example, to be used to hemolyze a blood sample and to analyze the hemo!ysate.
  • the second microchannel 28 is intended, for example, to be used to analyze a whole blood sample.
  • the third microchannel 30 may be used for an alternative analysis.
  • the microfluidic channel system 22 further comprises a fourth microchannel 32 which comprises a plurality of submierochan eis 34, 38, 38, 40, and 42 whic treat subsarop!es of a biood sampie applied to the microfiuidic distributing device 10.
  • the device may contain less or more than four microchannels, such as one, two, three, five, six, seven, eight, nine, or ten or more microchanneis, and less than or more than one microchannei which comprises submicrocha eis, such as zero, two, three, or four, or more, or any combination thereof.
  • Each of the microchannels 28, 28, 30, and 32 has a treatment sampie apportionment channel 44a, 44b, 44c, and 44d, respectively, which is connected to and in fluid communicatio with the fluid sampie entry port 24, More peulariy, treatment sampie apportionment channels 44a-44d receive portions of the fluid sample which is introduced into the fluid sampie entry port 24.
  • each microchannei 26, 28, 30, and 32 may be supplied with its own fluid sampie entry port.
  • vaives 46a ⁇ 46c are in fluid communication with vaive exit channels 48a-48c which are in turn connected to and in fluid communication with reagent areas 50a ⁇ 50c.
  • the vaives 46a-48c may be constaicted so as to prevent baekfSow of a sample after it has passed therethrough.
  • valve means a device that may be controlled or actuated to control or regulate fluid, gas or solution flow between and among various components of the microfiuidic device, including flow between flow channels, solvent or reagent reservoirs, reaction chamber, columns, manifold, temperature controlling elements and devices, and the like.
  • vaives may include mechanical (or mieromec anical valves), (pressure activated) eiasfomerie valves, pneumatic valves, and solid-state vaives. Examples of such valves and their method of fabrication may be found, for example, in "The New Generation of Microva!ves” Analytical Chemistry, Felton, 429- 432 (2003).
  • valve exit channels 48a-48c to reagent areas 50a-50c, respectively, where the portions of the fluid samples are reacted with one or more reagents in the reagent areas 50a-S0c
  • a single reageni area of the device may contain multiple reagents.
  • Each reagent area 50a-50c generally contains one or more reagents which are reacted with the fluid sample which flows thereinto. Mixing of the fluid sample portion with the reagent may also occur in the reagent area.
  • the term "reagent area" may refer to more than one discrete chamber which contains a reagent.
  • a reagent area may comprise two separate reagent sub- chambers such that the fluid sample enters the first reagent sub-chamber where it reacts with a first reagent then is passed to a second reagent sub-chamber where the reacted fluid sample further reacts with a second reagent in the second reagent sub-chamber.
  • the fluid samples After the fluid samples have been reacted in reagent areas 50a-50c, they are passed into reagent area exit channels 52a-52c, respectively.
  • These reagent area exit channels 52a-52c are connected to and in fluid communication with metering areas 54a-54e, respectively.
  • the fluid samples pass into the metering area 54a- 5 c where specifically measured portions of the fluid sample are passed into output channels 58a ⁇ 56c, respectively, and out through exit ports 58a-58c, respectively, where the reacted and metered fluid samples may be delivered to test devices (FIGS. 3-7), which are able to analyze the reacted fluid samples which have exited through the exit ports 58a-58c.
  • Each output channel 58a ⁇ 56c optionally includes a closure valve 57a-57e, respectively, for enabling the corresponding output channel 56a-56c to be closed.
  • th closure valves 57a-57c may be actuated to close the output channels 56a ⁇ 58c after samples have been treated i the microfiuidic distributing device 10 but before the device 10 has been attached to a test device for analyzing the treated sample.
  • the reagents in the reagent areas 50a-50c may be disposed on or i a substrate or on an inner surface of the reagent area 50a-50c.
  • reagents may be deposited on a surfac of any one or more of apportionment channels 448-440, valve exit channels 48a-48c, reagent area exit channels 52a-52c, and output channels 56a-56c, where such a reagent wouid serve a useful purpose in accordance with the presently disclosed and claimed inventive concepts such as to provide an anti-coagulant to prevent coagulation of a blood sample passing throug the assay path.
  • Reagent area 50a is shown in phantom to represent that reagent area 50a may or may not be present as a discrete entity.
  • the portion of the fluid sample received by apportionment channel 44d is delivered to a valve 60 for further apportionment and distribution of the fluid sample into the submicrochanneis 34-42 of the microchannel 32 (the apportionment channel 44d may aiso be referred to herein as a main microchannel). More particularly, in the embodiment of FIGS. 1 and 2, as noted above, the microchannel 32 has five separate submicrochanneis 34-42 for processing subsamples of the fluid sample held by the valve 80.
  • Each submicrochannel 34-42 begins with a corresponding subapportionment channel 62a-82e, respectively, which extends from and is in fluid communication with the valve 80 and which is connected to and in fluid communication wit a corresponding valve 643-646, respectively, which controls the flow (particularly inhibiting backfiow) of the subsample into a corresponding reagent area 68a ⁇ 68e via a corresponding valve exit channel 66a ⁇ 66e, respectively.
  • the reagent areas 88a-68e are similar in nature to the reagent areas 50a- 50c described above but generally contain different reagents.
  • the reagents in reagent areas 68a-88e may be anticoagulants such as EDTA, NaF, heparin, oxalate, citrate, or any other substance known by persons have ordinary skill in the art of blood or plasma analysis.
  • Each fluid subsample, once having been treated with the corresponding reagent is transported to a cell (e.g., blood ceil) separation area 72a-72e, respectively, via a reagent area exit channel 70a-70e, which is i fluid communication with the corresponding reagent area 68a-68 and wit the respective cell separation area 72a-72e.
  • a cell separation area 72a-72e the cells are separated from the fluid (e.g. , blood cells separated from plasma) which enables more efficient and accurate measurement of the desired aspect of the purified fluid (e.g., plasma) by a test device.
  • the ceil separation mechanism in the ceil separation areas may be any feature, mechanism, device, or process by which blood cells are separated from plasma including, but not limited to, cenirifugation, asymmetric membranes, tangential flow membranes, ultrasound, microti uidics, agglutination, adhesion, other physical blockage elements, or any combination of the above.
  • the treated fluid portion of the subsample is transferred to a corresponding metering area 76a-76e via a separation area exit channel 74a-74e which is in fluid communication with the corresponding eel! separation area 72a-72e.
  • each treated fluid (e.g., plasma) portion is metered into a specifically measured portion which is passed to a corresponding exit port 80a-80e via an output channel 78a-78e which is connected to, and in fluid communication with, the corresponding metering area 78a- 76e and exit port 80a ⁇ 8Qe.
  • metering areas 54a-54c and 76a-76 may optionally be omitted from the corresponding microchannel or submicrochannel if such is not necessary for the microchannel to function in accordance with the presently disclosed and claimed inventive concepts, for example, if the entire subsample leaving the reagent area 50a ⁇ 50e or 88a-68e is to be analyzed.
  • Each output channel 78a-78c optionally includes a closure valve 79a ⁇ 79c, respectively, for enabling the corresponding output channel to be ciosed.
  • the closur valves 79a-79c may b actuated to close the output channels 78a-78c after samples have been treated in the microfluidic distributing device 10 but before the device i 0 has been attached to a test device for analyzing the treated sample.
  • the microfluidic analysis system 100 comprises a base 102 having an upper surface 103.
  • a plurality of test devices designated by the general reference numerals 104, 106, 108, 1 10, 112, 1 14, 116, and 18, are positioned upon the upper surface 103 of the base 102.
  • Each test device 104-1 18 has an entry port 105, 107, 109, 11 1 , 1 13, 1 15, 1 17, and 1 19, respectively.
  • each test device 104- 18 is secured to the base 102 either frictiona!!y or by insertion or by other securing mechanisms well known to persons of ordinary skill in the art, such as, but not limited to, snaps, fasteners, ridges, and tabs,
  • a microfluidic distributing device 10 as described previously, is disposed on the base 102, and as with the test devices 104-1 18, is usually secured to the base 102 either fictionally (for example by insertion into a cavity in the base 102) or by other securing mechanisms known in the art, for example as described above (although reference in the embodiment of FIG. 3 and other analysts systems beiow is made to the use of the microfiuidic distributing device 10, it is intended that any microfSusdic distributing device described and/or contemplated herein or which function in accordance with the presently disclosed and claimed inventive concepts may be used in a microfiuidic analysis systems described herein).
  • the base 102 further comprises a plurality of transfer conduits 120, 122, 124, 126, 128, 130, 132, and 134.
  • each transfer conduit 120-134 is positioned so as to be connected to one of the exit ports of the microfiuidic distributing devic 10 at one end of the corresponding transfer conduit, and with a corresponding entry port of the test device at the other end of the corresponding transfer conduit.
  • F!G the embodiment of F!G.
  • exit port 80a is fiuidiy connected to entry port 105 of test device 104 by transfer conduit 120
  • exit port 80b is fiuidiy connected to entry port 107 of test device 106 by transfer conduit 122
  • exit port 80c is fiuidiy connected to entry port 109 of test device 108 by transfer conduit 124
  • exit port 80d is fiuidiy connected to entry port 111 of test device 1 10 by transfer conduit 126
  • exit port 80e is fiuidiy connected to entry port 13 of test device 12 by transfer conduit 12
  • exit port 58c is fiuidiy connected to entry port 115 of test device 1 4 by transfer conduit 130
  • exit port 58b is fiuidiy connected to entry port 117 of test device 116 by transfer conduit 132
  • exit port 58a is fiuidiy connected to entry port 119 of test device 118.
  • the fluid subsamples in the microchannels thereof can be transferred via the transfer conduits 120-134 to the test devices 104-1 18, respectively, for testing of the fluid subsamples in accordance with the desired analyses thereof.
  • the transfer of the fluid subsamples into the test devices 104-1 18 and analyses therein of the fluid samples can occur simultaneously or independently, or sequentially, in accordance with the desired analyses.
  • the microfluidic distributing device 10 can be disposed upon or otherwise attached to the base 102 before a fluid sample is disposed within the entry port 24 of microfluidic distributing device 10, or after a fluid sample is disposed within the entry port 24. Also, the microfluidic distributing device 10 can be activated to process the fluid sample before the microfluidic distributing device 10 is placed on the base 102, or after the microfluidic distributing device 10 is placed on the base 102.
  • FIG. 4 Shown in FIG, 4 and designated therein by the general reference numeral 200 is another microfluidic analysis system constructed in accordance with the presently disclosed and claimed inventive concepts.
  • the microfluidic analysis system 200 is similar In many respects to the microfluidic analysis system 100 of FIG. 3 except for the manner in which the microfluidic distributing device 10 is secured for testing.
  • the microfluidic analysis system 200 comprises a base 202 having an upper surface 203.
  • a plurality of test devices designated by the general reference numerals 204, 208, 208, 210, 212 t 214, 218, and 218 t are positioned upon the upper surface 203 of the base 202.
  • Each test device 204-218 has an entr port 205, 207, 209, 211 , 213, 215, 217, and 219, respectively.
  • each test device 204-218 is secured to the base 202 either frictionally or by insertion or by other securing mechanisms well known to persons of ordinary skill in the art, such as, but not limited to, snaps, fasteners, ridges, and tabs.
  • a microfluidic distributing device 10, as described previously, is attached to the base 202 by insertion into an engaging mechanism 240 such that the device 10 is securely connected (removably or non-removably) to the base 202.
  • the engaging mechanism 240 may be any suitable mechanism known in the art.
  • the base 202 further comprises a plurality of iransfer conduits 220, 222, 224, 226, 228, 230, 232, and 234. As explained below, each transfer conduit 220-234 is positioned so as to connect with one of the exit ports of the microfiuidic distributing device 10 at one end of the corresponding transfer conduit, and with a corresponding entry port of the test device at the other end of the corresponding transfer conduit, in the case of the embodiment of FIG.
  • exit port 80a is fluidiy connected to entry port 205 of test device 204 by transfer conduit 220
  • exit port 80b is fluidiy connected to entry port 207 of test device 208 by transfer conduit 222
  • exit port 80c is fluidiy connected to entry port 209 of test device 208 by transfer conduit 224
  • exit port 80d is fluidiy connected to entry port 21 1 of test device 210 by transfer conduit 226
  • exit port 80e is fluidiy connected to entry port 2 3 of test device 212 by transfer conduit 228, exit port 58c is fluidiy connected to entry port 215 of test device 2 4 by transfer conduit 230
  • exit port 58b is fluidiy connected to entry port 217 of test device 216 by transfer conduit 232
  • exit port 58a is fluidiy connected to entry port 219 of test device 218.
  • the fluid subsamples in the microchannels thereof can be transferred via the transfe conduits 220-234 to the test devices 204-218, respectivefy, for testing of the fluid subsamples in accordance with the desired analyses thereof.
  • the transfer of the fluid subsamples into the test devices 204-218 and analyses therein of the fluid samples can occur simultaneously or independently, or sequentially, in accordance with the desired analyses.
  • the microfiuidic distributing device 10 can be disposed upon or otherwise attached to the base 202 before a fluid sample is disposed within the entry port 24 of microfiuidic distributing device 10, or after a fluid sample is disposed within the entry port 24. Also, the microfiuidic distributing device 10 can be activated to process the fluid sample before the microfiuidic distributing device 10 is attached to the base 202 ; or after the microfiuidic distributing device 10 is attached to the base 202.
  • FIG. 3 Shown in FIG, 5 and designated therein by the genera! reference numeral 300 is a microfiuidic analysis system constructed in accordance with the presently disclosed and claimed inventive concepts.
  • the microfiuidic analysis system 300 is similar in many respects to the microfiuidic analysis system 100 of FIG. 3 except for the manner in which the microfiuidic distributing device 10 is secured to the base and how the exit ports of the microfiuidic distributing device 10 are aligned with the test devices, ore particularly, the microfiuidic analysis system 300 comprises a base 302 having an upper surface 303.
  • each test device 304-318 has an entry port 305, 307, 309, 311 , 313, 315, 317, and 319, respectively.
  • each test device 304-318 is secured to the base 302 either frictiona!!y or by other securing mechanisms well known to persons of ordinary skil! in the art, such as, but not limited to, snaps, fasteners, ridges, and tabs.
  • a microfiuidic distributing device 10 is movabiy disposed on the base 302, such that the microfiuidic distributing device 10 can be shifted manually or automatically, in a direction 340 (or the reverse), suc that the exit ports 80a-80e and 58c ⁇ 58a can be aligned with the corresponding entry ports 305-319 of test devices 302-318 by moving the microfiuidic distributing device 10 on the base 302.
  • the base 302 further comprises a plurality of transfer conduits 320, 322, 324, 326, 328, 330, 332, and 334.
  • Each transfer conduit 320-334 is positioned so as to connect with one of the exit ports of the microfiuidic distributing device 10 at one end of the corresponding transfer conduit, and with a corresponding entry port of the test device at the other end of the corresponding transfer conduit, in the case of the embodiment of FIG.
  • exit port 80a is f!uidly conneciabia to entry port 305 of test device 304 by transfer conduit 320
  • exit port 80b is fluid !y connectabie to entry port 207 of test device 206 by transfer conduit 322
  • exit port 80c is fiuidiy connectabie to entry port 309 of test device 308 by transfer conduit 324
  • exit port 80d is fiuidiy connectabie to entry port 311 of test device 310 by transfer conduit 326
  • exit port 80e is fiuidiy connectabie to entry port 313 of test device 312 by transfer conduit 328
  • exit port 58c is fiuidiy connectabie to entry port 3 5 of test device 314 by transfer conduit 330
  • exit port 58b is fiuidiy connectabie to entry port 317 of test device 318 by transfer conduit 332
  • exit port 58a is fiuidiy connectabie to entry port 319 of test device 318.
  • the fluid sufosamples in the microchanneis thereof can be transferred via the transfer conduits 320-334 to the test devices 304-318, respectively, for testing of the fiuid subsamples in accordance with the desired anaiyses thereof.
  • the transfer of the fluid subsampies can occur serially or non- seriaiiy in accordance with the desired analyses.
  • the microfiuidic distributing device 10 can be disposed upon or otherwise attached to the base 302 before a fluid sample is disposed within the entry port 24 of microfiuidic distributing device 10, or after a fluid sampie is disposed within the entry port 24. A!so, the microfiuidic distributing device 10 can be activated to process the fiuid sampie before the microfiuidic distributing device 10 is placed on the base 302, or after the microfiuidic distributing device 10 is placed on the base 302. [0074] Shown in FIG. 6 and designated therein by the general reference numeral 400 is another embodiment of a microfiuidic analysis system constructed in accordance wit the presently disclosed and claimed inventive concepts.
  • the rnicrofSusdic analysis system 400 comprises a base 402 having a plurality of test devices designated by the genera! reference numerals 404, 408, 408, 410, 412, 414, 416, and 418, which are positioned vertically in the base 402.
  • Each test device 404- 418 has an entry port (not shown) which is simiiar to the entry ports of the test devices 104-118.
  • the test device 404-418 may be secured in the base 402 either frictionaiiy or by other securing mechanisms well known to persons of ordinary skii! in the art, such as, but not limited to, snaps, fasteners, ridges, and tabs.
  • the base 402 further comprises a microfiuidic device holder 403 which inciudes a track, rail, or other suitable mechanism which enables a microfiuidic distributing device of the presently disclosed and claimed inventive concepts (such as microfiuidic distributing device 10) to be shifted vertically in direction 440, or downwardly in relation to the orientation of the test devices 404-418.
  • a microfiuidic device holder 403 which inciudes a track, rail, or other suitable mechanism which enables a microfiuidic distributing device of the presently disclosed and claimed inventive concepts (such as microfiuidic distributing device 10) to be shifted vertically in direction 440, or downwardly in relation to the orientation of the test devices 404-418.
  • a microfiuidic distributing device 10 is positioned within the microfiuidic device holder 403 whereby the microfiuidic distributing device 0 may be shifted up or down for transferring a fluidic sample into the test devices 404-418 serially.
  • the base 402 further comprises a plurality of transfer conduits (not shown) wherein each exit port of the microfiuidic distributing device 10 can be placed in fluid communication with a corresponding transfer conduit which is in fluid communication with an entry port of a corresponding test device.
  • the fluidic connections are not shown in the embodiment of FIG. 6, but are intended to be similar to those shown, for example, in the microfiuidic analysis system 300 of FIG. 5.
  • the fluid subsamples in the microchannels thereof therein can be transferred via transfer conduits to the test devices 404-418, respectively, for testing of the fiu id subsamples in accordance with the desired analyses thereof.
  • the transfer of the fluid subsamples generally occurs serially, consecutively, or non ⁇ consecutively.
  • the microfluidic distributing device 10 can be inserted into or otherwise attached to the microfluidic device holder 403 before a fluid sampie is disposed within the entry port 24 of microfluidic distributing device 10, or after a fluid sampie is disposed within the entry port 24. Also, the microfluidic distributing device 10 can be activated to process the fluid sample before the microfluidic distributing device 10 is placed in the microfluidic device hoider 403, or after the microfluidic distributing device 10 is placed on the microfluidic device hoider 403.
  • the general reference numeral 500 is another embodiment of a microfluidic analysis system constructed in accordance with the presently disclosed and claimed inventive concepts. Operation of the microfluidic analysis system 500 is substantially similar to that of system 100 s excep for the shape of the components thereof.
  • the microfluidic analysis system 500 comprises a disk-shaped base 502 having an upper surface 503, A plurality of test devices designated by the genera! reference numerals 504, 506, 508, 510, 512, 514, 518, and 518, are positioned radially upon the upper surface 503 of the base 502.
  • Each test device 504-518 has an entry port 505, 507, 509, 51 , 513, 515, 517, and 519, respectively.
  • eac test device 504-518 is secured to the base 500 either frictiona!ly or by other securing mechanisms well known to persons of ordinary skill in the art, such as, but not limited to, snaps, fasteners, ridges, and tabs as discussed above.
  • the base 502 further comprises a plurality of transfer conduits 520, 522, 524, 526, 528, 530, 532, and 534.
  • Each transfer conduit 520-534 is positioned so as to connect with one of the exit ports (not shown, but similar to the exit ports of microfluidic distributing device 10) of the microfluidic distributing device 10a at one end of the corresponding transfer conduit, and with a corresponding entry port of the test device at the other end of the corresponding transfer conduit.
  • an exit port of microfluidic distributing device 10a is fiuidiy connected to entry port 505 of test device 504 by transfer conduit 520
  • a exit port of microfluidic distributing device 10a is fiuidiy connected to entry port 507 of test device 506 by transfer conduit 522
  • an exit port of microfluidic distributing device 10a is fiuidiy connected to entry port 509 of test device 508 by transfer conduit 524
  • an exit port of microfluidic distributing device 10a is fiuidiy connected to entry port 511 of test device 5 0 by transfer conduit 526
  • an exit port of microfluidic distributing device 10a is fiuidiy connected to entry port 513 of test device 512 by transfer conduit 528
  • a exit port of microfluidic distributing device 10a is fiuidiy connected to entry port 515 of test device 514 by transfer conduit 530
  • a exit port of microfluidic distributing device 10a is fiuidiy connected to
  • the fluid subsamples therein can be transferred via the transfer conduits 520-534 to the test devices 504-518, respectively, fo testing of the fluid subsamples in accordance with the desired analyses thereof.
  • the transfer of the fluid subsamples into the test devices 504-518 can occur simultaneously or independently, or sequentially, in accordance with the desired analyses.
  • the microfluidic distributing device 10a can be rotated to align the microfluidic distributing device 10a with the proper transfer conduits 520-534 on the base 502.
  • the microfluidic distributing device 10a can be disposed upon or otherwis attached to the base 502 before a fluid sample is disposed within an entry port (not shown) thereof, or after a fluid sample is disposed within th said entry port. A!so, the microfluidic distributing device 10a can be activated to process the fluid sample before the microfluidic distributing device 0a is placed on the base 502, or after the microfluidic distributing device 10a is placed on the base 502.
  • Fluid samples and subsamples thereof may be propelled into and through the microcihanneSs of the microfluidic distributing devices described herein by passive or active fluidics including, but not limited to, capiiiary force, syringe pump, pistons, pneumatic, actuators, cent ifugation, solenoids, linear actuators, peristaltic pump, electrophoresis, memory alloy valves, surface acoustic wave, or combinations of the above.
  • Types of valves that may be used include, but are not limited to, check valves, on/off valves, memory alloy valves, solenoids, linear actuators, or any other valve which functions to control, stop, or start flow of the fluid samples.
  • the fluid samples and subsamples thereof may be mixed before, during, or after exposure to the reagents in the reagent areas.
  • Mixing may be by passive or active mechanisms.
  • passive mechanisms include, but are not limited to, herring bone features, posts, or chevrons
  • active mechanisms include, but are not limited to, piezo electric motors, surface acoustic wave means, centrifugal force, electrophoresis, and magnetic movement of particles, and combinations thereof,
  • Reagent areas as described herein, wherei the fluid samples may be held for mixing, reaction with reagents, or both, iypically have a width i a range of, but not limited to, 0.5 mm to 3 mm, and have a dept in a range of, but not limited to : 0,2 mm to 3.0 mm, and have a length in a range of, but not limited to, 1 mm to 25 mm.
  • Metering areas as described herein may have similar dimensions, but also may have greater lengths, depths, or widths depending on the volume of the fluid subsample desired to be exposed to the test devices used with the microfluidic distributing devices of the presently disclosed and claimed inventive concepts.
  • the dimensions of the fluid sampie entry port 24 are typically (but not limited to) in the range of 0.2 mm to 3.0 mm (depth) and 0,2 mm to 3,0 mm (diameter).
  • Reagents may be disposed or deposited in the reagent areas (or elsewhere in the microchannel) as dry powders, !yophilized spheres or granules, dried on a surface of the reagent area chamber, as liquids, for example, in pouches or blister packs, or on substrates as discussed elsewhere herein.
  • an anticoagulant e.g., heparin
  • Samples to be hemo!yzed will generally require a surfactant or lysing agent ⁇ e.g., Saponin) in the reagent area or upstream thereof.
  • the microchannel may be absent a discrete reagent area such that the surfactant or lysing agent may simply be deposited in a channel between the vaive and the exit port (or metering area, if present).
  • the mierochannels described herein are shown generally as linear thereby allowing a substantially straight-line flow of fluid therethrough, ft is to be understood, however, that the present inventive concepts are not limited to straight flow paths and may comprise curved, angled, or otherwise non-linear microchannel flow paths.
  • Si is to be further understood that a first portion of a microchannel may be straight, and a second portion of the same microchannel may be curved, angled, or otherwise non -linear.
  • the microf!uidic distributing device of the presently disclosed and claimed inventive concepts may further include one or more sensors i fluids c communication with the microchannel for detecting some aspect of the subsample therein.
  • sensors are well known in the art, and therefore no further discussion thereof is deemed necessary.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

L'invention concerne un dispositif de distribution microfluidique comprenant une pluralité de microcanaux pour l'analyse d'un échantillon de fluide (tel que du sang). Le dispositif de distribution microfluidique comprend un orifice d'entrée d'échantillon de fluide à partir duquel des sous-échantillons de l'échantillon de fluide sont distribués à la pluralité de microcanaux dans lesquels les sous-échantillons de fluide sont traités pour analyse par de dispositifs de test.
PCT/US2014/025753 2013-03-15 2014-03-13 Dispositif de distribution microfluidique WO2014151450A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US14/776,172 US9416776B2 (en) 2013-03-15 2014-03-13 Microfluidic distributing device
KR1020157029250A KR101653701B1 (ko) 2013-03-15 2014-03-13 미세유체 분배 장치
EP14769287.5A EP2972331B1 (fr) 2013-03-15 2014-03-13 Dispositif de distribution microfluidique
CN201480014839.9A CN105026932B (zh) 2013-03-15 2014-03-13 微流控分配设备
US15/206,669 US10105701B2 (en) 2013-03-15 2016-07-11 Microfluidic distributing device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361790580P 2013-03-15 2013-03-15
US61/790,580 2013-03-15

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/776,172 A-371-Of-International US9416776B2 (en) 2013-03-15 2014-03-13 Microfluidic distributing device
US15/206,669 Continuation US10105701B2 (en) 2013-03-15 2016-07-11 Microfluidic distributing device

Publications (1)

Publication Number Publication Date
WO2014151450A1 true WO2014151450A1 (fr) 2014-09-25

Family

ID=51580961

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/025753 WO2014151450A1 (fr) 2013-03-15 2014-03-13 Dispositif de distribution microfluidique

Country Status (5)

Country Link
US (1) US10105701B2 (fr)
EP (1) EP2972331B1 (fr)
KR (1) KR101653701B1 (fr)
CN (1) CN105026932B (fr)
WO (1) WO2014151450A1 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016049527A1 (fr) * 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Dispositif de cartouche avec système fluidique segmenté pour effectuer des essais de coagulation dans des échantillons liquides
WO2016049533A1 (fr) * 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Dispositif cartouche avec jonctions fluidiques pour mesures de coagulation dans des échantillons de fluide
US9903877B2 (en) 2014-09-26 2018-02-27 Abbott Point Of Care Inc. Sensors for assaying coagulation in fluid samples
US9921232B2 (en) 2014-09-26 2018-03-20 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10114031B2 (en) 2014-09-26 2018-10-30 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples
US10247741B2 (en) 2014-09-26 2019-04-02 Abbott Point Of Care Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
US10288628B2 (en) 2014-04-11 2019-05-14 Siemens Healthcare Diagnostics Inc. Spectroscopic methods for the detection of glycated hemoglobin
US10371643B2 (en) 2013-03-15 2019-08-06 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays
US10371661B2 (en) 2013-03-15 2019-08-06 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays utilizing electrochemical discharge of singlet oxygen and methods of production and use thereof
US10473612B2 (en) 2014-09-26 2019-11-12 Abbott Point Of Care Inc. Cartridge device identification for coagulation assays in fluid samples
US10519410B2 (en) 2015-08-26 2019-12-31 Emulate, Inc Pressure manifold and culture module
WO2020171693A1 (fr) * 2019-02-21 2020-08-27 Consorcio De Investigación E Innovación Abierta S.A.P.I. De C.V. Appareil pour le traitement immunohistochimique de plusieurs échantillons histologiques
US20220349877A1 (en) * 2017-05-04 2022-11-03 Siemens Healthcare Diagnostics Inc. Devices and methods for minimizing hook effect inteference in immunoassays

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10710083B2 (en) * 2016-04-15 2020-07-14 University Of Maryland Integrated thermoplastic chip for rapid PCR and HRMA
BR112018074337B1 (pt) 2016-07-26 2021-05-04 Hewlett-Packard Development Company, L.P aparelhos microfluídicos e método
KR101675383B1 (ko) 2016-08-26 2016-11-11 (주)엠비아이 아이들 제어가 가능한 듀얼 일방향 클러치 및 이를 구비한 변속기
DE102016222032A1 (de) * 2016-11-10 2018-05-17 Robert Bosch Gmbh Mikrofluidische Vorrichtung und Verfahren zur Analyse von Nukleinsäuren
EP3401013A1 (fr) * 2017-05-12 2018-11-14 Universitat de Barcelona Dispositifs et procédés de multiplexage de liquide dans les micro-cavités d'un biocapteur
US11527324B2 (en) 2017-11-10 2022-12-13 Reliant Immune Diagnostics, Inc. Artificial intelligence response system based on testing with parallel/serial dual microfluidic chip
US11200986B2 (en) 2017-11-10 2021-12-14 Reliant Immune Diagnostics, Inc. Database and machine learning in response to parallel serial dual microfluidic chip
US10930381B2 (en) * 2017-11-10 2021-02-23 Reliant Immune Diagnostics, Inc. Microfluidic testing system for mobile veterinary applications
US11124821B2 (en) * 2017-11-10 2021-09-21 Reliant Immune Diagnostics, Inc. Microfluidic testing system with cell capture/analysis regions for processing in a parallel and serial manner
US10930380B2 (en) * 2017-11-10 2021-02-23 Reliant Immune Diagnostics, Inc. Communication loop and record loop system for parallel/serial dual microfluidic chip
US11041185B2 (en) 2017-11-10 2021-06-22 Reliant Immune Diagnostics, Inc. Modular parallel/serial dual microfluidic chip
CN109825431A (zh) * 2019-03-18 2019-05-31 中国人民解放军军事科学院军事医学研究院 寡核苷酸原位组装仪
US20220168727A1 (en) * 2019-03-24 2022-06-02 Mehul BALDWA Biosensor for detection of analytes in a fluid
CN109929749B (zh) * 2019-03-27 2021-07-27 深圳市尚维高科有限公司 自驱动微流控芯片及其使用方法
CN110146477B (zh) * 2019-05-31 2023-08-04 成都博奥晶芯生物科技有限公司 一种浓度梯度校准芯片的制备方法及其校准方法
CN113544515A (zh) * 2020-02-21 2021-10-22 京东方科技集团股份有限公司 微流控结构、微流控系统、微流控方法和制造微流控结构的方法
CN111536274A (zh) * 2020-05-06 2020-08-14 北京美联泰科生物技术有限公司 多液路选向阀及一体化多通道液路模块
TWI762948B (zh) * 2020-06-11 2022-05-01 豐康微流體晶片股份有限公司 應用於微流控晶片之快速拆接之密封匹配接頭模組
CN112945637A (zh) * 2021-01-28 2021-06-11 上海浚真生命科学有限公司 取样装置
CN112892626B (zh) * 2021-01-29 2022-11-04 上海天马微电子有限公司 一种微流控装置及其制造方法
WO2022243869A1 (fr) * 2021-05-18 2022-11-24 Johnson & Johnson Consumer Inc. Échantillonnage de fluide biologique et surveillance pour un suivi approfondi et un test du stress
US20240216910A1 (en) * 2021-05-25 2024-07-04 Genz Biyo Teknolo Ji Anonim Sirketi Microfluidic chip and its production
CN113368915A (zh) * 2021-06-28 2021-09-10 上海交通大学 一种高通量培养脑类器官的微流控芯片
WO2023028667A1 (fr) * 2021-09-06 2023-03-09 Haemograph Pty Ltd Système de pré-chargement de réactif et dispositif de mesure
CN113634295B (zh) * 2021-09-14 2022-11-04 南京岚煜生物科技有限公司 一种微流控血型检测芯片
CN118043347A (zh) * 2021-09-30 2024-05-14 美国西门子医学诊断股份有限公司 用于抗sars-cov-2抗体的双重免疫测定的组合物、试剂盒和方法
WO2024063764A1 (fr) * 2022-09-21 2024-03-28 Google Llc Empilement de dosage et système de collecte d'un échantillon cible pour essai

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296126B1 (en) 1998-12-23 2001-10-02 Microparts Gesellschaft Device for removing a liquid from capillaries
US20020166592A1 (en) * 2001-02-09 2002-11-14 Shaorong Liu Apparatus and method for small-volume fluid manipulation and transportation
US6632404B1 (en) 2000-08-02 2003-10-14 Symyx Technologies, Inc. Automatically actuated parallel sample injector valve
US20050013732A1 (en) * 2003-01-21 2005-01-20 Micronics, Inc. Method and system for microfluidic manipulation, amplification and analysis of fluids, for example, bacteria assays and antiglobulin testing
US20050041525A1 (en) * 2003-08-19 2005-02-24 Pugia Michael J. Mixing in microfluidic devices
US20050176135A1 (en) 2004-02-06 2005-08-11 Brian Jones Cassette for isolation, amplification and identification of DNA or protein and method of use
US20080014576A1 (en) 2006-02-03 2008-01-17 Microchip Biotechnologies, Inc. Microfluidic devices
US20080085551A1 (en) * 2006-10-10 2008-04-10 Postech Academy-Industry Foundation Microfluidic biochip for blood typing based on agglutination reaction
WO2008052168A2 (fr) 2006-10-26 2008-05-02 Symyx Technologies, Inc. Réacteur à lit fixe parallèle à haute pression et son procédé
US20090036668A1 (en) * 2007-04-12 2009-02-05 Siemens Medical Solutions Usa, Inc. Microfluidic radiosynthesis system for positron emission tomography biomarkers
US20090246866A1 (en) * 2006-06-06 2009-10-01 Werner Naser Ready-to-use whole blood collection vessel
US20090283452A1 (en) * 2006-11-30 2009-11-19 Palo Alto Research Center Incorporated Method and apparatus for splitting fluid flow in a membraneless particle separation system
US20090317798A1 (en) * 2005-06-02 2009-12-24 Heid Christian A Analysis using microfluidic partitioning devices

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066448A (en) 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US7374906B2 (en) * 2000-11-08 2008-05-20 Surface Logix, Inc. Biological assays using gradients formed in microfluidic systems
US6418968B1 (en) * 2001-04-20 2002-07-16 Nanostream, Inc. Porous microfluidic valves
US6880576B2 (en) * 2001-06-07 2005-04-19 Nanostream, Inc. Microfluidic devices for methods development
US6981522B2 (en) * 2001-06-07 2006-01-03 Nanostream, Inc. Microfluidic devices with distributing inputs
AU2002319668A1 (en) 2001-07-27 2003-02-17 President And Fellows Of Harvard College Laminar mixing apparatus and methods
US7459127B2 (en) 2002-02-26 2008-12-02 Siemens Healthcare Diagnostics Inc. Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
US7476326B2 (en) 2003-09-26 2009-01-13 Ahn Chong H On-chip sample preparation for whole blood analysis
KR100843339B1 (ko) 2006-12-07 2008-07-03 한국전자통신연구원 혈액 중의 혈장 분리를 위하여 마이크로채널을 이용한혈장분리기 및 이에 의한 혈장분리방법
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
SG10201606120XA (en) 2007-10-02 2016-09-29 Theranos Inc Modular Point-Of-Care Devices And Uses Thereof
IT1393855B1 (it) 2009-04-22 2012-05-11 Consiglio Nazionale Ricerche Dispensatore elettrodinamico di liquidi in quantita' micro/nano-litriche basato sull'effetto piroelettrico in materiali funzionalizzati, senza l'impiego di sorgenti elettriche esterne.
US8496889B2 (en) * 2010-03-23 2013-07-30 California Institute Of Technology Microfluidic device for separating and sorting particles in a fluid medium
CN102822680B (zh) * 2010-03-25 2015-10-21 恩德莱斯和豪瑟尔测量及调节技术分析仪表两合公司 用于处理液体的系统
EP2490020A1 (fr) * 2011-02-18 2012-08-22 Koninklijke Philips Electronics N.V. Puce de mesure, dispositif microfluidique et procédé de fabrication du puce de mesure
US10865440B2 (en) 2011-10-21 2020-12-15 IntegenX, Inc. Sample preparation, processing and analysis systems

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296126B1 (en) 1998-12-23 2001-10-02 Microparts Gesellschaft Device for removing a liquid from capillaries
US6632404B1 (en) 2000-08-02 2003-10-14 Symyx Technologies, Inc. Automatically actuated parallel sample injector valve
US20020166592A1 (en) * 2001-02-09 2002-11-14 Shaorong Liu Apparatus and method for small-volume fluid manipulation and transportation
US20050013732A1 (en) * 2003-01-21 2005-01-20 Micronics, Inc. Method and system for microfluidic manipulation, amplification and analysis of fluids, for example, bacteria assays and antiglobulin testing
US20050041525A1 (en) * 2003-08-19 2005-02-24 Pugia Michael J. Mixing in microfluidic devices
US20050176135A1 (en) 2004-02-06 2005-08-11 Brian Jones Cassette for isolation, amplification and identification of DNA or protein and method of use
US20090317798A1 (en) * 2005-06-02 2009-12-24 Heid Christian A Analysis using microfluidic partitioning devices
US20080014576A1 (en) 2006-02-03 2008-01-17 Microchip Biotechnologies, Inc. Microfluidic devices
US20090246866A1 (en) * 2006-06-06 2009-10-01 Werner Naser Ready-to-use whole blood collection vessel
US20080085551A1 (en) * 2006-10-10 2008-04-10 Postech Academy-Industry Foundation Microfluidic biochip for blood typing based on agglutination reaction
WO2008052168A2 (fr) 2006-10-26 2008-05-02 Symyx Technologies, Inc. Réacteur à lit fixe parallèle à haute pression et son procédé
US20090283452A1 (en) * 2006-11-30 2009-11-19 Palo Alto Research Center Incorporated Method and apparatus for splitting fluid flow in a membraneless particle separation system
US20090036668A1 (en) * 2007-04-12 2009-02-05 Siemens Medical Solutions Usa, Inc. Microfluidic radiosynthesis system for positron emission tomography biomarkers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"The New Generation of Microvalves", ANALYTICAL CHEMISTRY, 2003, pages 429 - 432
VAUGHT, J.B.: "Blood Collection, Shipment, Processing, and Storage", CANCER EPIDEMIOL BIOMARKERS PREV., vol. 15, September 2006 (2006-09-01), pages 1582

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10371661B2 (en) 2013-03-15 2019-08-06 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays utilizing electrochemical discharge of singlet oxygen and methods of production and use thereof
US10371643B2 (en) 2013-03-15 2019-08-06 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays
US10288628B2 (en) 2014-04-11 2019-05-14 Siemens Healthcare Diagnostics Inc. Spectroscopic methods for the detection of glycated hemoglobin
US10473612B2 (en) 2014-09-26 2019-11-12 Abbott Point Of Care Inc. Cartridge device identification for coagulation assays in fluid samples
US10598675B2 (en) 2014-09-26 2020-03-24 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples
US10048282B2 (en) 2014-09-26 2018-08-14 Abbott Point Of Care Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
US10114031B2 (en) 2014-09-26 2018-10-30 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples
US10247741B2 (en) 2014-09-26 2019-04-02 Abbott Point Of Care Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
US9921232B2 (en) 2014-09-26 2018-03-20 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10352951B2 (en) 2014-09-26 2019-07-16 Abbott Point Of Care Inc. Sensors for assaying coagulation in fluid samples
US9903877B2 (en) 2014-09-26 2018-02-27 Abbott Point Of Care Inc. Sensors for assaying coagulation in fluid samples
WO2016049533A1 (fr) * 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Dispositif cartouche avec jonctions fluidiques pour mesures de coagulation dans des échantillons de fluide
WO2016049527A1 (fr) * 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Dispositif de cartouche avec système fluidique segmenté pour effectuer des essais de coagulation dans des échantillons liquides
US11391747B2 (en) 2014-09-26 2022-07-19 Abbott Point Of Care Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
US10048281B2 (en) 2014-09-26 2018-08-14 Abbott Point Of Care Inc. Cartridge device with segmented fluidics for assaying coagulation in fluid samples
US11156620B2 (en) 2014-09-26 2021-10-26 Abbott Point Of Care Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
US10746749B2 (en) 2014-09-26 2020-08-18 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10913924B2 (en) 2015-08-26 2021-02-09 EMULATE, Inc. Controlling pressure
US10988721B2 (en) 2015-08-26 2021-04-27 EMULATE, Inc. Controlling pressure
US10988722B2 (en) 2015-08-26 2021-04-27 EMULATE, Inc. Perfusion manifold assembly
US10689608B2 (en) 2015-08-26 2020-06-23 EMULATE, Inc. Droplet fluid connections
US10519410B2 (en) 2015-08-26 2019-12-31 Emulate, Inc Pressure manifold and culture module
US11820966B2 (en) 2015-08-26 2023-11-21 EMULATE, Inc. Pressure manifold and culture module
US11834641B2 (en) 2015-08-26 2023-12-05 EMULATE, Inc. Controlling pressure
US11920114B2 (en) 2015-08-26 2024-03-05 EMULATE, Inc. Controlling pressure
US20220349877A1 (en) * 2017-05-04 2022-11-03 Siemens Healthcare Diagnostics Inc. Devices and methods for minimizing hook effect inteference in immunoassays
WO2020171693A1 (fr) * 2019-02-21 2020-08-27 Consorcio De Investigación E Innovación Abierta S.A.P.I. De C.V. Appareil pour le traitement immunohistochimique de plusieurs échantillons histologiques

Also Published As

Publication number Publication date
EP2972331A4 (fr) 2017-01-04
US10105701B2 (en) 2018-10-23
EP2972331A1 (fr) 2016-01-20
EP2972331B1 (fr) 2018-10-17
KR101653701B1 (ko) 2016-09-02
KR20150130523A (ko) 2015-11-23
CN105026932A (zh) 2015-11-04
CN105026932B (zh) 2017-06-13
US20160318019A1 (en) 2016-11-03

Similar Documents

Publication Publication Date Title
US10105701B2 (en) Microfluidic distributing device
US9416776B2 (en) Microfluidic distributing device
US7125711B2 (en) Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
AU2011211319B2 (en) Centrifugal micro-fluidic device and method for detecting analytes from liquid specimen
US7459127B2 (en) Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
US8394336B2 (en) Biochemical assay
EP2133150B1 (fr) Dispositif d'étiquetage sur disque
US20040265172A1 (en) Method and apparatus for entry and storage of specimens into a microfluidic device
JP2006121935A (ja) 前処理手段および廃液貯留部を有する生体物質検査用マイクロリアクタ
US20180141038A1 (en) Single cartridge for multiple detection modalities
US11859734B2 (en) Valve for microfluidic device
Nelson Design principles for microfluidic biomedical diagnostics in space
US20200238279A1 (en) Devices, systems, and methods for specimen preparation and analysis using capillary and centrifugal forces

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201480014839.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14769287

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14776172

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2014769287

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20157029250

Country of ref document: KR

Kind code of ref document: A